Zentalis Pharmaceuticals annual operating margin
2024
Zentalis Pharmaceuticals's operating margin was −283.57% for fiscal 2024.
View full Zentalis Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −283.57% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −185.55% | — |
| Q1 2024 | 2024-03-31 | −61.06% | — |
The latest reported quarter, Q4 2024, shows −185.55%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zentalis Pharmaceuticals source filings ↗